RMAX vs DRUG

Comparison between RE/MAX Holdings Inc - Class A (RMAX, Company) and Bright Minds Biosciences Inc (DRUG, Company).

RMAX is from the Real Estate sector, while DRUG is from the Healthcare sector.

5-Year PerformanceDRUG has outperformed RMAX, delivering a return of +27.0% compared to -21.5%

RMAX vs DRUG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RMAX(COMPANY)	DRUG(COMPANY)
Market Cap	$722M	$724M
Max Drawdown	91.58%	97.68%
Sharpe Ratio	0.32	1.67
5Y Beta	1.09	-0.76
Industry	Real Estate Services	Biotechnology
P/E Ratio	31.40	-30.67
Forward P/E	12.08	N/A
PEG Ratio	4.07	-0.08
5Y Dividends CAGR	3.68%	N/A
5Y EPS CAGR	N/A	8.42%
Debt to Equity	97.72%	0.03%
Free Cash Flow Yield	4.62%	-2.01%
P/S Ratio	1.96	N/A
P/B Ratio	0.51	3.49

Market Cap

RMAX

$722M

Winner

DRUG

$724M

Max Drawdown

Winner

RMAX

91.58%

DRUG

97.68%

Sharpe Ratio

RMAX

0.32

Winner

DRUG

1.67

5Y Beta

RMAX

1.09

Winner

DRUG

-0.76

Industry

RMAX

Real Estate Services

DRUG

Biotechnology

P/E Ratio

RMAX

31.40

Winner

DRUG

-30.67

Forward P/E

RMAX

12.08

DRUG

N/A

PEG Ratio

RMAX

4.07

Winner

DRUG

-0.08

5Y Dividends CAGR

RMAX

3.68%

DRUG

N/A

5Y EPS CAGR

RMAX

N/A

DRUG

8.42%

Debt to Equity

RMAX

97.72%

Winner

DRUG

0.03%

Free Cash Flow Yield

Winner

RMAX

4.62%

DRUG

-2.01%

P/S Ratio

RMAX

1.96

DRUG

N/A

P/B Ratio

Winner

RMAX

0.51

DRUG

3.49

RMAX vs DRUG - Historical Returns

Returns include dividend reinvestment.

Period	RMAX	DRUG
1 month	-5.52%	+9.46%
3 months	+41.01%	-19.61%
6 months	+16.21%	-18.06%
1 year	+6.81%	+138.59%
5 years(CAGR)	-21.49%	+26.98%
10 years(CAGR)	-12.67%	N/A
Max(CAGR)	-6.07%	+19.96%

RMAX

-5.52%

Winner

DRUG

+9.46%

Winner

RMAX

+41.01%

DRUG

-19.61%

Winner

RMAX

+16.21%

DRUG

-18.06%

RMAX

+6.81%

Winner

DRUG

+138.59%

5Y(CAGR)

RMAX

-21.49%

Winner

DRUG

+26.98%

10Y(CAGR)

RMAX

-12.67%

DRUG

N/A

Max(CAGR)

RMAX

-6.07%

Winner

DRUG

+19.96%

RMAX vs DRUG - Annual Returns (2013 - 2026)

Returns include dividend reinvestment.

Year	RMAX	DRUG
2026	+25.00%	-14.58%
2025	-26.67%	+89.83%
2024	-15.59%	+1859.10%
2023	-26.98%	-63.33%
2022	-36.49%	-78.04%
2021	-10.39%	-41.30%
2020	-0.26%	N/A
2019	+25.87%	N/A
2018	-35.34%	N/A
2017	-12.28%	N/A
2016	+55.66%	N/A
2015	+14.50%	N/A
2014	+7.35%	N/A
2013	+18.78%	N/A

RMAX vs DRUG Drawdown Comparison

The maximum drawdown for RMAX was -89.94%, occurring on Apr 1, 2026. This drawdown has not yet recovered.

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The current RMAX drawdown is -83.56%. The current DRUG drawdown is -25.73%.

Rank	RMAX	DRUG
#1	-89.94% Oct 27, 2017 - Apr 1, 2026	-97.68% Nov 8, 2021 - Oct 18, 2024
#2	-29.16% Nov 11, 2015 - Jul 21, 2016	-58.28% Nov 6, 2024 - Sep 29, 2025
#3	-20.13% Dec 27, 2013 - Nov 21, 2014	-38.35% Jan 7, 2026 - Jun 15, 2026
#4	-16.91% Jan 22, 2015 - Jul 6, 2015	-27.84% Mar 22, 2021 - Aug 24, 2021
#5	-13.71% Oct 4, 2013 - Dec 23, 2013	-26.13% Oct 21, 2025 - Nov 28, 2025
#6	-12.52% Feb 23, 2017 - Aug 4, 2017	-19.30% Dec 16, 2025 - Jan 7, 2026
#7	-12.08% Aug 4, 2015 - Nov 6, 2015	-16.21% Sep 30, 2025 - Oct 9, 2025
#8	-10.97% Dec 5, 2014 - Jan 22, 2015	-14.42% Oct 11, 2021 - Nov 3, 2021
#9	-9.10% Aug 4, 2017 - Oct 4, 2017	-9.05% Oct 24, 2024 - Nov 4, 2024
#10	-6.67% Jul 27, 2016 - Sep 7, 2016	-7.65% Oct 14, 2025 - Oct 21, 2025
#11	-6.40% Oct 24, 2016 - Nov 7, 2016	-5.42% Dec 11, 2025 - Dec 16, 2025
#12	-6.33% Sep 7, 2016 - Sep 22, 2016	-4.62% Sep 24, 2021 - Sep 29, 2021
#13	-6.24% Jan 4, 2017 - Feb 6, 2017	-4.59% Dec 8, 2025 - Dec 10, 2025
#14	-6.00% Sep 22, 2016 - Oct 24, 2016	-4.38% Aug 24, 2021 - Sep 1, 2021
#15	-5.29% Nov 14, 2016 - Nov 25, 2016	-3.81% Sep 1, 2021 - Sep 17, 2021

Correlation

Correlation between RMAX and DRUG is -0.33 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.33

-101